期刊
BRAIN SCIENCES
卷 11, 期 12, 页码 -出版社
MDPI
DOI: 10.3390/brainsci11121654
关键词
Parkinson's disease; COVID-19; SARS-CoV-2; neurodegeneration; Alzheimer's disease; viral infection
资金
- PRACTIS-Clinician Scientist Program of Hannover Medical School - German Research Foundation (DFG) [ME 3696/3-1]
Research on the connection between COVID-19 and Parkinson's disease is ongoing, with some evidence suggesting a potential increase in neurodegenerative diseases following the SARS-CoV-2 pandemic. However, current data are not sufficient to confirm whether COVID-19 can directly trigger or accelerate neurodegenerative diseases.
The SARS-CoV-2 pandemic has affected the daily life of the worldwide population since 2020. Links between the newly discovered viral infection and the pathogenesis of neurodegenerative diseases have been investigated in different studies. This review aims to summarize the literature concerning COVID-19 and Parkinson's disease (PD) to give an overview on the interface between viral infection and neurodegeneration with regard to this current topic. We will highlight SARS-CoV-2 neurotropism, neuropathology and the suspected pathophysiological links between the infection and neurodegeneration as well as the psychosocial impact of the pandemic on patients with PD. Some evidence discussed in this review suggests that the SARS-CoV-2 pandemic might be followed by a higher incidence of neurodegenerative diseases in the future. However, the data generated so far are not sufficient to confirm that COVID-19 can trigger or accelerate neurodegenerative diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据